Holick MF, Brinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.全文  摘要


1. Bischof F, Basu D, Pettifor JM. Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa. Dev Med Child Neurol. 2002;44:119-122.全文  摘要

2. Adamson BB, Gallacher SJ, Byars J, et al. Mineralisation defects with pamidronate therapy for Paget's disease. Lancet. 1993;342:1459-1460. 摘要

3. Silve C. Hereditary hypophosphatasia and hyperphosphatasia. Curr Opin Rheumatol. 1994;6:336-339. 摘要

4. Luni FK, Khan AR, Prashar R, et al. Fanconi syndrome and antiretrovirals: it is never too late. Am J Ther. 2016;23:e558-e560. 摘要

5. Patel SM, Graff-Radford J, Wieland ML. Valproate-induced Fanconi syndrome in a 27-year-old woman. J Gen Intern Med. 2011;26:1072-1074.全文  摘要

6. Knights M, Thekkekkara T, Morris A, et al. Sodium valproate-induced Fanconi type proximal renal tubular acidosis. BMJ Case Rep. 2016 Jan 28;2016:.全文  摘要

7. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373.全文  摘要

8. Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009 Jul;32(7):1278-83.全文  摘要

9. Song HR, Kweon SS, Choi JS, et al. High prevalence of vitamin D deficiency in adults aged 50 years and older in Gwangju, Korea: the Dong-gu Study. J Korean Med Sci. 2014 Jan;29(1):149-52.全文  摘要

10. Harris NS, Crawford PB, Yangzom Y, et al. Nutritional and health status of Tibetan children living at high altitudes. N Engl J Med. 2001 Feb 1;344(5):341-7.全文  摘要

11. Sedrani SH. Are Saudis at risk of developing vitamin D deficiency? Saudi Med J. 1986;7:427-433.

12. Drezner MK, McGuire JL, Marks SC. Metabolic bone disease. In: Kelley W, ed. Textbook of internal medicine. 2nd ed. Philadelphia, PA: Lippincott; 1992.

13. Finch PJ, Ang L, Eastwood JB, et al. Clinical and histological spectrum of osteomalacia among Asians in South London. Q J Med. 1992;83:439. 摘要

14. Ashwell M, Stone EM, Stolte H, et al. UK Food standards agency workshop report: an investigation of the relative contributions of diet and sunlight to vitamin D status. B J Nutr. 2010;104:603-611. 摘要

15. Holick MF, Brinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.全文  摘要

16. Eddy RL. Metabolic bone disease after gastrectomy. Am J Med. 1971;50:442. 摘要

17. Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35:544-557. 摘要

18. Dalcanale L, Oliveira CP, Faintuch J, et al. Long-term nutritional outcome after gastric bypass. Obesity Surg. 2010;20:181-187. 摘要

19. Al-Shoha A, Qiu S, Palnitkar S, et al. Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract. 2009;15:528-533. 摘要

20. Karefylakis C, Näslund I, Edholm D, et al. Vitamin D status 10 years after primary gastric bypass: gravely high prevalence of hypovitaminosis D and raised PTH levels. Obes Surg. 2014;24:343-348. 摘要

21. Martin KJ, Slatopolsky E. Renal osteodystrophy. In: Becker KL, Bilezikian JP, Remner WJ, et al., eds. Principles and practice of endocrinology and metabolism. New York, NY: J.B. Lippincott Company; 1990:457-463.

22. Takeuchi Y, Suzuki H, Ogura S, et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab. 2004;89:3979.全文  摘要

23. Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217-221. 摘要

24. Ott SM, Maloney NA, Klein GL, et al. Aluminium is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med. 1983;98:910. 摘要

25. Wang Y, Yin Y, Gilula LA, et al. Endemic fluorosis of the skeleton: radiographic features in 127 patients. AJR Am J Roentgenol. 1994;162:93-98.全文  摘要

26. Cystic Fibrosis Trust. European cystic fibrosis bone mineralisation guidelines. Feb 2011 [internet publication].全文  摘要

27. Russell JA. Osteomalacic myopathy. Muscle Nerve. 1994;17:578-580. 摘要

28. Marie PJ, Pettifor JM, Ross FP, et al. Histological osteomalacia due to dietary calcium deficiency in children. N Engl J Med. 1982;307:584-588. 摘要

29. Bishop N. Rickets today: children and sunshine (editorial). N Engl J Med. 1999;341:602. 摘要

30. De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57. 摘要

31. De Boer WA, Tytgat GN. A patient with osteomalacia as single presenting symptom of gluten-sensitive enteropathy. J Intern Med. 1992;232:81. 摘要

32. Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional rickets. 2016 Jan 8 [Epub ahead of print].全文  摘要

33. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860-868. 摘要

34. Reddy Munagala VV, Tomar V. Images in clinical medicine: osteomalacia. N Engl J Med. 2014;370:e10.全文  摘要

35. Chen TL, Hirst MA, Cone CM, et al. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured skin fibroblasts from patients and parents. J Clin Endocrinol Metab. 1984;59:383-388. 摘要

36. Eguchi H, Tsuruta M, Tani J, et al. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med. 2014;53:233-237.全文  摘要

37. Brow TT. Challenges in the management of osteoporosis and vitamin D deficiency in HIV infection. Top Antivir Med. 2013;21:115-118.全文  摘要

38. Clarke BL, Wynne AG, Wilson DM, et al. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf). 1995;43:479-490. 摘要

39. Holick MF. Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol. 2008;624:1-15. 摘要

40. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC. The National Academies Press. 2011 [internet publication].全文

41. Holick MF. Vitamin D: a D-lightful solution for health. J Investig Med. 2011;59:872-880. 摘要

42. National Osteoporosis Foundation. Get the facts on calcium and vitamin D. http://www.nof.org/ (last accessed 9 May 2016).全文

43. Scientific Advisory Committee on Nutrition. Jul 2016 [internet publication].全文

44. Klein GL. Nutritional rickets and osteomalacia. In: Favus M, et al., ed. Primer on metabolic bone disease and disorders of mineral metabolism. Philadelphia, PA: Lippincott-Raven; 1993.

45. Kaur G, Singh P, Mittal N, et al. Resolution of "salt and pepper" appearance of the skull with vitamin D therapy. Indian J Endocrinol Metab. 2013;17:S194-S197.全文  摘要

46. Saghafi M, Azarian A, Hashemzadeh K, et al. Bone densitometry in patients with osteomalacia: is it valuable? Clin Cases Miner Bone Metab. 2013;10:180-182.全文  摘要

47. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536-1538.全文  摘要

48. Carter T, Nutt J, Simons A, et al. Bilateral femoral neck insufficiency fractures secondary to vitamin D deficiency and concurrent corticosteroid use - a case report. Arch Osteoporos. 2014;9:172. 摘要

49. Aloia JF, Dhaliwal R, Shieh A, et al. Calcium and vitamin D supplementation in postmenopausal women. J Clin Endocrinol Metab. 2013;98:E1702-E1709. 摘要

50. Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med. 1978 Dec;89(6):966-82. 摘要

51. Bingham CT, Fitzpatrick LA. Noninvasive testing in the diagnosis of osteomalacia. Am J Med. 1993;95:519. 摘要

52. Basha B, Rao DS, Han ZH, et al. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med. 2000;108:296. 摘要

53. Chong WH, Molinolo AA, Chen CC, et al. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18:R53-R77.全文  摘要

54. Carpenter TO, Imel EA, Holm IA, et al. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26:1381-1388.全文  摘要

55. Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;24;928-930. 摘要

56. Trang HM, Cole DE, Rubin LA, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854. 摘要

57. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008:93;677-81.全文  摘要

58. Verge CF, Lam A, Simpson JM, et al. Effects of therapy in X-linked hypophosphatemic rickets. N Eng J Med. 1991;325:1843-1848. 摘要

59. Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998;13:12380. 摘要

60. Koutkia P, Lu Z, Chen TC, et al. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology. 2001;121:1485-1488. 摘要

61. Tangpricha V, Turner A, Spina C, et al. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004;80:1645.全文  摘要

62. Imel EA, Glorieux FH, Whyte MP, et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 2019 Jun 15;393(10189):2416-2427.全文  摘要

63. Insogna KL, Rauch F, Kamenický P, et al. Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial. J Bone Miner Res. 2019 Dec;34(12):2183-2191.全文  摘要

64. Day AL, Gutiérrez OM, Guthrie BL, et al. Burosumab in tumor-induced osteomalacia: A case report. Joint Bone Spine. 2020 Jan;87(1):81-83.全文  摘要

65. Carpenter TO, Miller PD, Weber TJ, et al. OR29-06 Burosumab improves biochemical, skeletal, and clinical features of tumor-induced osteomalacia syndrome. J Endocr Soc. 2020 May 8;4(Suppl 1):OR29-06.全文